A 71-year-old man with STEMI post-PCI asks about chest pain pathways in the ED for future episodes. Which biomarker approach is preferred for ruling o...

Question

A 71-year-old man with STEMI post-PCI asks about chest pain pathways in the ED for future episodes. Which biomarker approach is preferred for ruling out MI when appropriate?

Accepted Answer

High-sensitivity troponin-based accelerated algorithms with clinical risk assessment

Answer

CK-MB serial testing only

Answer

No biomarkers; ECG alone

Answer

Myoglobin point-of-care testing

Answer

Troponin drawn 12 hours after onset only

us-abem MCQ (SBA): ACS Evaluation

A 71-year-old man with STEMI post-PCI asks about chest pain pathways in the ED for future episodes. Which biomarker approach is preferred for ruling out MI when appropriate?